sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
±ûÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ±ûÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó

ǰÑÔ

²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡  £¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ  £¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒß  £¬¿Éͬʱ»òÏȺóѬȾ  £¬»ìÏýѬȾ»òÖØµþѬȾ  £¬Ê¹Ö¢×´¼ÓÖØ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷ࣭¿ÚÈö²¥ÎªÖ÷  £¬³£¼û·¢ÈÈ¡¢»Æ¾Ò  £¬³Ê¼±ÐÔ¾­ÓÉ  £¬ÓÐÊýǨÑÓ³ÉÂýÐÔ£»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ×  £¬¶à¾­ÊäѪ»òÑªÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥  £¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯  £¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹ØÏµ£»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ  £¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖØµþѬȾ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ×¶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó¡£

±ûÐ͸ÎÑײ¡¶¾(hepatitis C virus,HCV)ÊÇÒ»µ¥¹ÉÕýÁ´RNA²¡¶¾  £¬¿ÉÒýÆð¼±ÐÔºÍÂýÐÔ²¡¶¾ÐÔ±ûÐ͸ÎÑ×(hepatitis C)  £¬¿ÉÉú³¤³É¸ÎÏËά»¯¡¢¸ÎÓ²»¯ÉõÖÁ¸Îϸ°û°©¡£HCV³ÊÈ«ÇòÐÔÊ¢ÐÐ  £¬Æ¾Ö¤ÌìÏÂÎÀÉú×éÖ¯µÄͳ¼Æ  £¬HCVÔÚÈËȺÖеÄѬȾÂÊԼΪ3%  £¬È«ÇòÔ¼ÓÐ1.7ÒÚÈËѬȾHCV  £¬Ã¿Äêз¢±ûÐ͸ÎÑײ¡ÀýÔ¼3.5ÍòÀý¡£ÎÒ¹ú¾ÙÐеÄÌìÏÂHCVѪÇåÊ¢Ðв¡Ñ§ÊÓ²ìÏÔʾ  £¬ÎÒ¹úÒ»Ñùƽ³£ÈËȺ¿¹HCVÑôÐÔÂÊΪ3.2%  £¬Ô¼ÓÐ4000ÍòÈËѬȾHCV¡£Ïà±ÈHBV  £¬ÔÚÎÒ¹úHCVѬȾÊܵ½µÄÖØÊÓˮƽ»¹²»·ó¡£Ïà¹ØÑо¿Ò²ºÍÍâÑóÓнϴó²î±ð  £¬±¾²¿·Ö¾ÍÏÖÔÚHCVÑо¿Óö¯ÎïÄ£×Ó×÷Ò»ÏÈÈÝ  £¬¹©Ïà¹ØÁìÓòÑо¿Õ߲ο¼¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎºÚÐÉÐÉ¡¢Ê÷üš¡¢´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

±ûÐ͸ÎÑײ¡¶¾Èö²¥Í¾¾¶Óë°¬×̲¡¶¾ºÍÒҸβ¡¶¾ÏàËÆ  £¬Ö÷Òª¾­ÊäѪ¡¢Ä¸Ó¤ºÍÐÔÈö²¥  £¬½«HCV»¼ÕßѪÇå»òϸ°û×÷ÓýµÄHCVcc¾²Âö×¢Éäµ½¶¯ÎïÌåÄÚ  £¬ÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾ±ûÐ͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ºÚÐÉÐÉ(pan troglodytes)£ºÓÃHCV»¼ÕßÑªÖÆÆ·Í¨¹ý¾²Âö×¢ÉäºÚÐÉÐÉ  £¬»ò½«ÌåÍâ×ªÂ¼ÖÆ±¸µÄHCV RNA×¢Éäµ½ºÚÐÉÐɸÎÔàÖÐ  £¬¿ÉʹºÚÐÉÐÉѬȾHCV²¡¶¾¡£ºÚÐÉÐÉѬȾHCVºó·ºÆðת°±Ã¸Éý¸ß  £¬¸Î»î¼ì·ºÆð¼±ÐÔ»µËÀÐÔÑ×Ö¢¸Ä±ä¡£

Ê÷üš£ºÓÃHCV»¼ÕßѪÇå»òϸ°û×÷Óý»ñµÃµÄHCV²¡¶¾(HCVcc)ͨ¹ý¾²Âö»ò¸ÎÔà¶àµã×¢Éä·½·¨×¢Éäµ½Ê÷üšÌåÄÚ  £¬¿ÉʹÊ÷üšÑ¬È¾HCV²¢·ºÆð¼äЪÐÔ²¡¶¾ÑªÖ¢¡£

´óÊ󣺽«ÈËÔ­´ú¸Îϸ°ûijÈ˸ΰ©Ï¸°ûHuh7¸¹Ç»×¢Éäµ½ÔÐÁäÔÚ15~17ÌìµÄÌ¥ÊóÖÐ  £¬²¢ÔÚ³öÉú24СʱÄÚÏòÆäÒÆÖ²ÈËÔ­´ú¸Îϸ°û»òHuh7  £¬Ê¹Ì¥ÊóµÄÃâÒßϵͳÔÚ·¢ÓýÀú³Ì»ñµÃ¶ÔÕâЩϸ°ûµÄÃâÒßÄÍÊÜ  £¬ËæºóÏò´óÊó½ÓÖÖ´Ó»¼ÕßѪÇåÊèÉ¢µ½µÄHCV  £¬¿ÉʹÆä»ñµÃ¶ÔHCVµÄѬȾÐÔ¡£

¡¾Ä£×ÓÌØµã¡¿£º

ºÚÐÉÐÉÊÇHCVµÄ×ÔÈ»ËÞÖ÷  £¬ÔÚѬȾHCVºó¿ÉÒÔ×ÔȻɨ³ý²¡¶¾  £¬ÂýÐÔЯ´øÕß²»»áÉú³¤Îª¸ÎÓ²»¯»ò¸ÎÏËά»¯  £¬²¢¶Ô×ÌÈÅËØÖÎÁÆÎÞЧ¡£ºÚÐÉÐÉѬȾHCVºóÖ»ÓиöÌå±»±¨µÀ×îºóÉú³¤Îª¸Îϸ°û¸Î°©¡£

Ê÷üšÑ¬È¾HCVÄܱ¬·¢Ë²Ê±²¡¶¾ÑªÖ¢  £¬HCV¿¹Ìå¡¢ALT¡¢HCV RNAÑôÐÔ¡£ÑôÐÔÊ÷üšµÄѪ½¬Í¬Ñù¿ÉÒÔѬȾÐÂÊ÷üš  £¬Ê÷üšÑ¬È¾HCVºó¸ÎÀïÖ¯²¡Àí¸Ä±äÀú³ÌÓëÈËÀà±ûÐ͸ÎÑ×µÄÏ£ÍûÒ»Ö  £¬¼´ÂýÐÔ¸ÎÑ×→¸ÎÖ¬·¾±ä→¸ÎÓ²»¯→¸Î°©¡£Í¼7-1/ÎÄÄ©²Êͼ7-1ʾÊ÷üšÑ¬È¾HCVºó¸ÎÔಡÀí¸Ä±äÇéÐΡ£

´óÊóÔÚHCVѬȾ4ÖܺóÔÚѪÇåÖпɼì²âµ½7.0×103¿½±´Êý£¯ml HCV RNA, 12ÖܺóHCV RNAµÖ´ï·åÖµ20×103¿½±´Êý£¯ml  £¬Ö®ºó×îÏÈϽµ¡£±û°±Ëá°±»ù×ªÒÆÃ¸ÔÚ4ÖÜ×îÏÈÉý¸ß  £¬µÚ13ÖÜÃÜ´ïá¯Áë  £¬Ö®ºó×îÏÈϽµ¡£ÏÔ΢¾µÏ¿ɼû¸ÎÃźÍÖÐÑëÇøÓòµ¥ºËϸ°û½þÈó¡£

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú 

ͼ7-1 Ê÷üšÑ¬È¾HCVºó¸ÎÔಡÀí¸Ä±äÇéÐÎ

×¢£ºA£®±ÈÕÕ×飺Õý³£¸Î×éÖ¯(H&E×400);B-F£®Ê÷ÔÏѬȾHCVºó¸ÎÔಡÀíѧ¸Ä±ä£»B£®Ö¬·¾±äÐÔ¡¢µ¨Ö­ÓÙ»ý(H&E×200);C£®¸Îϸ°û¿ÕÅÝÑù±äÐÔ(H&E×400); D£®µ¨¹ÜËðÉË  £¬°é»ã¹ÜÇøÂýÐÔÑ×ϸ°û½þÈó(H&E×200);E£®ÃâÒß×黯HCV¿¹Ô­°ûÖÊÑôÐÔ(×400);F£®ÃâÒß×黯HCV¿¹Ô­°ûÖÊÆ¬Ôî×´ÑôÐÔ(×200)

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ºÚÐÉÐÉÊÇÏÖÔÚ³ýÈËÀàÍâΨһ¿ÉÒÔ±»HCVѬȾµÄÁ鳤ÀදÎï  £¬ºÚÐÉÐÉѬȾHCV  £¬ÆäÁÙ´²Àú³ÌÓëÈËÀàHCVѬȾÏàËÆ  £¬²¢Äܹ»ÐγÉÂýÐÔѬȾ  £¬ÂýÐÔЯ´øÕß²»»áÉú³¤Îª¸ÎÓ²»¯»ò¸ÎÏËά»¯¡£¿ÉÒÔÓÃÓÚÑо¿HCVµÄ¼±ÐÔѬȾ  £¬Ñо¿ÔÚ¼±ÐÔÆÚÄÚHCVµÄ²¡¶¾Ñ§×ª±äºÍËÞÖ÷µÄÃâÒß·´Ó¦£»Ñо¿HCV×ÔȻѬȾÀú³ÌÖв¡Àíѧ¡¢ÃâÒß·´Ó¦µÈ·½ÃæµÄת±äºÍHCVÒßÃçµÄÑз¢¡£µ«ºÚÐÉÐɲ»ÊʺÏÑо¿ÂýÐÔѬȾºÍÓëHCVÏà¹ØµÄ¸Îϸ°û¸Î°©¡£ÏÖÔÚ  £¬NIH ÒѾ­Õ¥È¡ÔÚÉúÎïҽѧÑо¿ÖÐʹÓúÚÐÉÐÉ¡£

Ê÷üšÊÇÒ»ÖÖÓÐÔ¶¾°µÄHCV¶¯ÎïÄ£×Ó  £¬ÒÅ´«½ø»¯ÉϱÈСÊó¡¢¼ÒÍõȸü¿¿½üÁ鳤ÀࡣѬȾHCVºó  £¬Äܱ¬·¢Ë²Ê±²¡¶¾ÑªÖ¢  £¬HCV¿¹Ìå¡¢ALT¡¢HCV RNAÑôÐÔ¡£¿ÉÓÃÓÚÑо¿HCVÈëÇֺ͸´ÖÆ»úÖÆ¡£

´óÊóÄ£×Ó»ñµÃµÄ¶¯ÎïÊÇÃâÒß¹¦Ð§Õý³£µÄ´óÊó  £¬ ¿ÉÓÃÓÚÑо¿HCVµÄÈëÇÖ¡¢¸´ÖÆ¡¢ÃâÒ߽鵼µÄ¸ÎËðÉ˺Í×÷ΪҩÎïɸ²éµÄ¹¤¾ß  £¬µ«ÓÉÓÚÌåÄÚÒÆÖ²µÄÈ˸ΰ©Ï¸°ûÊýÄ¿ÓÐÏÞ  £¬HCVѬȾºó²¡¶¾ÔØÁ¿µÍ  £¬Ò²ÏÞÖÆÁËÆäÓ¦Óá£

 

²Î¿¼ÎÄÏ×£º

1.ÄÏ´óº½  £¬ÅËÄþ  £¬ÕލÇí£®ÒÒÐ͸ÎÑ×¶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£©  £¬2012, 31 (4):504-507

2.¹¢¼Ò±¦  £¬ÍõÁá  £¬ÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾  £¬2010, 11(4):429-432

3.Õ²ÃÀÔÆ  £¬Áõ³ç°Ø  £¬Àî³ÉÃ÷  £¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆÑ§ÔºÑ§±¨  £¬1981, 3 (3):148-152

4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97

5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988

6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211

7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128

8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ±ûÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó
±ûÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×Ó

ǰÑÔ

²¡¶¾ÐÔ¸ÎÑ×(viral hepatitis)ÊÇÓɶàÖÖ²î±ð¸ÎÑײ¡¶¾ÒýÆðµÄÒ»×éÒÔ¸ÎÔàËðº¦ÎªÖ÷µÄѬȾ²¡  £¬¿É·ÖΪ¼×¡¢ÒÒ¡¢±û¡¢¶¡¡¢Îì¡¢¸ýÁùÖÖÀàÐÍ  £¬¸÷ÐÍÖ®¼äÎÞ½»Ö¯ÃâÒß  £¬¿Éͬʱ»òÏȺóѬȾ  £¬»ìÏýѬȾ»òÖØµþѬȾ  £¬Ê¹Ö¢×´¼ÓÖØ¡£¼×ÐͲ¡¶¾ÐÔ¸ÎÑ׺ÍÎìÐͲ¡¶¾ÐÔ¸ÎÑ×ÒԷ࣭¿ÚÈö²¥ÎªÖ÷  £¬³£¼û·¢ÈÈ¡¢»Æ¾Ò  £¬³Ê¼±ÐÔ¾­ÓÉ  £¬ÓÐÊýǨÑÓ³ÉÂýÐÔ£»ÒÒÐͲ¡¶¾ÐÔ¸ÎÑ׺ͱûÐͲ¡¶¾ÐÔ¸ÎÑ×  £¬¶à¾­ÊäѪ»òÑªÖÆÆ·ÒÔ¼°Ç×½ü½Ó´¥Èö²¥  £¬Ò×ǨÑÓÉú³¤³ÉÂýÐÔÉõÖÁ¸ÎÓ²»¯  £¬ÒÑ֤ʵÒÒÐͺͱûÐ͸ÎÑײ¡¶¾Ñ¬È¾Óë¸Î°©ÓÐÒ»¶¨¹ØÏµ£»¶¡ÐͲ¡¶¾ÐÔ¸ÎÑ×ÐèÒÀÀµÓÚÒÒÐ͸ÎÑײ¡¶¾¶ø±£´æ²¢¸´ÖÆ  £¬³£ÓëÒÒÐ͸ÎÑײ¡¶¾³Ê»ìÏýѬȾ»òÔÚÒÒÐ͸ÎÑײ¡¶¾ÑôÐÔµÄÂýÐÔÒҸβ¡³ÌÖÐÖØµþѬȾ¡£ÏÖÔÚ½¨ÉèµÄ²¡¶¾ÐÔ¸ÎÑ×¶¯ÎïÄ£×ÓÖ÷ÒªÓм×Ð͸ÎÑײ¡¶¾Ä£×Ó¡¢ÒÒÐ͸ÎÑײ¡¶¾Ä£×Ó¡¢±ûÐ͸ÎÑ× ²¡¶¾Ä£×ÓºÍÎìÐ͸ÎÑײ¡¶¾Ä£×Ó¡£

±ûÐ͸ÎÑײ¡¶¾(hepatitis C virus,HCV)ÊÇÒ»µ¥¹ÉÕýÁ´RNA²¡¶¾  £¬¿ÉÒýÆð¼±ÐÔºÍÂýÐÔ²¡¶¾ÐÔ±ûÐ͸ÎÑ×(hepatitis C)  £¬¿ÉÉú³¤³É¸ÎÏËά»¯¡¢¸ÎÓ²»¯ÉõÖÁ¸Îϸ°û°©¡£HCV³ÊÈ«ÇòÐÔÊ¢ÐÐ  £¬Æ¾Ö¤ÌìÏÂÎÀÉú×éÖ¯µÄͳ¼Æ  £¬HCVÔÚÈËȺÖеÄѬȾÂÊԼΪ3%  £¬È«ÇòÔ¼ÓÐ1.7ÒÚÈËѬȾHCV  £¬Ã¿Äêз¢±ûÐ͸ÎÑײ¡ÀýÔ¼3.5ÍòÀý¡£ÎÒ¹ú¾ÙÐеÄÌìÏÂHCVѪÇåÊ¢Ðв¡Ñ§ÊÓ²ìÏÔʾ  £¬ÎÒ¹úÒ»Ñùƽ³£ÈËȺ¿¹HCVÑôÐÔÂÊΪ3.2%  £¬Ô¼ÓÐ4000ÍòÈËѬȾHCV¡£Ïà±ÈHBV  £¬ÔÚÎÒ¹úHCVѬȾÊܵ½µÄÖØÊÓˮƽ»¹²»·ó¡£Ïà¹ØÑо¿Ò²ºÍÍâÑóÓнϴó²î±ð  £¬±¾²¿·Ö¾ÍÏÖÔÚHCVÑо¿Óö¯ÎïÄ£×Ó×÷Ò»ÏÈÈÝ  £¬¹©Ïà¹ØÁìÓòÑо¿Õ߲ο¼¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎºÚÐÉÐÉ¡¢Ê÷üš¡¢´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

±ûÐ͸ÎÑײ¡¶¾Èö²¥Í¾¾¶Óë°¬×̲¡¶¾ºÍÒҸβ¡¶¾ÏàËÆ  £¬Ö÷Òª¾­ÊäѪ¡¢Ä¸Ó¤ºÍÐÔÈö²¥  £¬½«HCV»¼ÕßѪÇå»òϸ°û×÷ÓýµÄHCVcc¾²Âö×¢Éäµ½¶¯ÎïÌåÄÚ  £¬ÓÕµ¼¶¯Îﱬ·¢ÀàËÆÓÚÈËÀà×ÔȻѬȾ±ûÐ͸ÎÑײ¡¶¾ºóµÄ¼²²¡Àú³Ì¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

ºÚÐÉÐÉ(pan troglodytes)£ºÓÃHCV»¼ÕßÑªÖÆÆ·Í¨¹ý¾²Âö×¢ÉäºÚÐÉÐÉ  £¬»ò½«ÌåÍâ×ªÂ¼ÖÆ±¸µÄHCV RNA×¢Éäµ½ºÚÐÉÐɸÎÔàÖÐ  £¬¿ÉʹºÚÐÉÐÉѬȾHCV²¡¶¾¡£ºÚÐÉÐÉѬȾHCVºó·ºÆðת°±Ã¸Éý¸ß  £¬¸Î»î¼ì·ºÆð¼±ÐÔ»µËÀÐÔÑ×Ö¢¸Ä±ä¡£

Ê÷üš£ºÓÃHCV»¼ÕßѪÇå»òϸ°û×÷Óý»ñµÃµÄHCV²¡¶¾(HCVcc)ͨ¹ý¾²Âö»ò¸ÎÔà¶àµã×¢Éä·½·¨×¢Éäµ½Ê÷üšÌåÄÚ  £¬¿ÉʹÊ÷üšÑ¬È¾HCV²¢·ºÆð¼äЪÐÔ²¡¶¾ÑªÖ¢¡£

´óÊ󣺽«ÈËÔ­´ú¸Îϸ°ûijÈ˸ΰ©Ï¸°ûHuh7¸¹Ç»×¢Éäµ½ÔÐÁäÔÚ15~17ÌìµÄÌ¥ÊóÖÐ  £¬²¢ÔÚ³öÉú24СʱÄÚÏòÆäÒÆÖ²ÈËÔ­´ú¸Îϸ°û»òHuh7  £¬Ê¹Ì¥ÊóµÄÃâÒßϵͳÔÚ·¢ÓýÀú³Ì»ñµÃ¶ÔÕâЩϸ°ûµÄÃâÒßÄÍÊÜ  £¬ËæºóÏò´óÊó½ÓÖÖ´Ó»¼ÕßѪÇåÊèÉ¢µ½µÄHCV  £¬¿ÉʹÆä»ñµÃ¶ÔHCVµÄѬȾÐÔ¡£

¡¾Ä£×ÓÌØµã¡¿£º

ºÚÐÉÐÉÊÇHCVµÄ×ÔÈ»ËÞÖ÷  £¬ÔÚѬȾHCVºó¿ÉÒÔ×ÔȻɨ³ý²¡¶¾  £¬ÂýÐÔЯ´øÕß²»»áÉú³¤Îª¸ÎÓ²»¯»ò¸ÎÏËά»¯  £¬²¢¶Ô×ÌÈÅËØÖÎÁÆÎÞЧ¡£ºÚÐÉÐÉѬȾHCVºóÖ»ÓиöÌå±»±¨µÀ×îºóÉú³¤Îª¸Îϸ°û¸Î°©¡£

Ê÷üšÑ¬È¾HCVÄܱ¬·¢Ë²Ê±²¡¶¾ÑªÖ¢  £¬HCV¿¹Ìå¡¢ALT¡¢HCV RNAÑôÐÔ¡£ÑôÐÔÊ÷üšµÄѪ½¬Í¬Ñù¿ÉÒÔѬȾÐÂÊ÷üš  £¬Ê÷üšÑ¬È¾HCVºó¸ÎÀïÖ¯²¡Àí¸Ä±äÀú³ÌÓëÈËÀà±ûÐ͸ÎÑ×µÄÏ£ÍûÒ»Ö  £¬¼´ÂýÐÔ¸ÎÑ×→¸ÎÖ¬·¾±ä→¸ÎÓ²»¯→¸Î°©¡£Í¼7-1/ÎÄÄ©²Êͼ7-1ʾÊ÷üšÑ¬È¾HCVºó¸ÎÔಡÀí¸Ä±äÇéÐΡ£

´óÊóÔÚHCVѬȾ4ÖܺóÔÚѪÇåÖпɼì²âµ½7.0×103¿½±´Êý£¯ml HCV RNA, 12ÖܺóHCV RNAµÖ´ï·åÖµ20×103¿½±´Êý£¯ml  £¬Ö®ºó×îÏÈϽµ¡£±û°±Ëá°±»ù×ªÒÆÃ¸ÔÚ4ÖÜ×îÏÈÉý¸ß  £¬µÚ13ÖÜÃÜ´ïá¯Áë  £¬Ö®ºó×îÏÈϽµ¡£ÏÔ΢¾µÏ¿ɼû¸ÎÃźÍÖÐÑëÇøÓòµ¥ºËϸ°û½þÈó¡£

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú 

ͼ7-1 Ê÷üšÑ¬È¾HCVºó¸ÎÔಡÀí¸Ä±äÇéÐÎ

×¢£ºA£®±ÈÕÕ×飺Õý³£¸Î×éÖ¯(H&E×400);B-F£®Ê÷ÔÏѬȾHCVºó¸ÎÔಡÀíѧ¸Ä±ä£»B£®Ö¬·¾±äÐÔ¡¢µ¨Ö­ÓÙ»ý(H&E×200);C£®¸Îϸ°û¿ÕÅÝÑù±äÐÔ(H&E×400); D£®µ¨¹ÜËðÉË  £¬°é»ã¹ÜÇøÂýÐÔÑ×ϸ°û½þÈó(H&E×200);E£®ÃâÒß×黯HCV¿¹Ô­°ûÖÊÑôÐÔ(×400);F£®ÃâÒß×黯HCV¿¹Ô­°ûÖÊÆ¬Ôî×´ÑôÐÔ(×200)

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

ºÚÐÉÐÉÊÇÏÖÔÚ³ýÈËÀàÍâΨһ¿ÉÒÔ±»HCVѬȾµÄÁ鳤ÀදÎï  £¬ºÚÐÉÐÉѬȾHCV  £¬ÆäÁÙ´²Àú³ÌÓëÈËÀàHCVѬȾÏàËÆ  £¬²¢Äܹ»ÐγÉÂýÐÔѬȾ  £¬ÂýÐÔЯ´øÕß²»»áÉú³¤Îª¸ÎÓ²»¯»ò¸ÎÏËά»¯¡£¿ÉÒÔÓÃÓÚÑо¿HCVµÄ¼±ÐÔѬȾ  £¬Ñо¿ÔÚ¼±ÐÔÆÚÄÚHCVµÄ²¡¶¾Ñ§×ª±äºÍËÞÖ÷µÄÃâÒß·´Ó¦£»Ñо¿HCV×ÔȻѬȾÀú³ÌÖв¡Àíѧ¡¢ÃâÒß·´Ó¦µÈ·½ÃæµÄת±äºÍHCVÒßÃçµÄÑз¢¡£µ«ºÚÐÉÐɲ»ÊʺÏÑо¿ÂýÐÔѬȾºÍÓëHCVÏà¹ØµÄ¸Îϸ°û¸Î°©¡£ÏÖÔÚ  £¬NIH ÒѾ­Õ¥È¡ÔÚÉúÎïҽѧÑо¿ÖÐʹÓúÚÐÉÐÉ¡£

Ê÷üšÊÇÒ»ÖÖÓÐÔ¶¾°µÄHCV¶¯ÎïÄ£×Ó  £¬ÒÅ´«½ø»¯ÉϱÈСÊó¡¢¼ÒÍõȸü¿¿½üÁ鳤ÀࡣѬȾHCVºó  £¬Äܱ¬·¢Ë²Ê±²¡¶¾ÑªÖ¢  £¬HCV¿¹Ìå¡¢ALT¡¢HCV RNAÑôÐÔ¡£¿ÉÓÃÓÚÑо¿HCVÈëÇֺ͸´ÖÆ»úÖÆ¡£

´óÊóÄ£×Ó»ñµÃµÄ¶¯ÎïÊÇÃâÒß¹¦Ð§Õý³£µÄ´óÊó  £¬ ¿ÉÓÃÓÚÑо¿HCVµÄÈëÇÖ¡¢¸´ÖÆ¡¢ÃâÒ߽鵼µÄ¸ÎËðÉ˺Í×÷ΪҩÎïɸ²éµÄ¹¤¾ß  £¬µ«ÓÉÓÚÌåÄÚÒÆÖ²µÄÈ˸ΰ©Ï¸°ûÊýÄ¿ÓÐÏÞ  £¬HCVѬȾºó²¡¶¾ÔØÁ¿µÍ  £¬Ò²ÏÞÖÆÁËÆäÓ¦Óá£

 

²Î¿¼ÎÄÏ×£º

1.ÄÏ´óº½  £¬ÅËÄþ  £¬ÕލÇí£®ÒÒÐ͸ÎÑ×¶¯ÎïÄ£×ÓÑо¿Ï£Íû. ¶«ÄÏ´óѧѧ±¨£¨Ò½Ñ§°æ£©  £¬2012, 31 (4):504-507

2.¹¢¼Ò±¦  £¬ÍõÁá  £¬ÖìÓÀºì£®ÊµÑéѬȾÎìÐ͸ÎÑײ¡¶¾¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÖйúÔ¤·ÀҽѧÔÓÖ¾  £¬2010, 11(4):429-432

3.Õ²ÃÀÔÆ  £¬Áõ³ç°Ø  £¬Àî³ÉÃ÷  £¬µÈ£®¼×Ð͸ÎÑײ¡¶¾Ñ¬È¾Ê÷üšµÄÆðÔ´Ñо¿£®Öйúҽѧ¿ÆÑ§ÔºÑ§±¨  £¬1981, 3 (3):148-152

4.Amado LA, Marchevsky RS,de Paula VS, el al. Experimental hepatitis A virus (HAV) infection in cynomolgus monkeys (Macaca fascicularÐÄ£ºevidence of active exlranepaticsite of HAV replication.Int J Exp Pathol, 2010, 91 (1):87-97

5.Dand.ri M, Burda MR, Torok E, et al. Repopulation of mouse Liver with human hepatocytes and in vivo infection wilh hepatilis B virus. Hepatology, 2001, 33 (4):981-988

6.Dorner M,Horwilz JA,Robbins JB,el al. A genetically humanized mouse model for hepatitis C virus Infection.Nature,2011,474(7350):208-211

7.Maneeral. Y, Clayson ET, Myint KS, et al. Experimental infection of the lahoratory rat with the hepatitis e virus. J Med Virol, 1996,48 (2): 121-128

8.Purcell RH, Emerson SU. Emerson. Animal Models of Hepatitis A and E. ILAR J, 2001, 42 (2): 161-177

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿